You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
9 January 2026 - Acousia Therapeutics GmbH, a clinical-stage biotechnology company based in Germany, announced on Thursday that it has completed patient enrolment in its Phase 2 PROHEAR clinical study of ACOU085 (INN: Bimokalner).Bimokalner is a prop...
9 January 2026 - Clinical-stage life sciences company ZYUS Life Sciences Corporation (TSXV:ZYUS) on Thursday reported favourable preliminary results from its ongoing Phase 2a UTOPIA-1 (Unique Treatment of Oncology Pain in Advanced Cancer) trial evalu...
9 January 2026 - DELFI Diagnostics Inc, a developer of next-generation, blood-based tests to help detect cancer, announced on Thursday the appointment of Cindy Soriano as chief financial officer, effective immediately.Soriano brings 20 years of finan...
8 January 2026 - Saluda Medical, Inc. (ASX: SLD), an American commercial-stage medical device company, said on Thursday that its next-generation EVA Sensing Technology has received CE certification for commercialisation in Europe, with recognition of...
8 January 2026 - US healthcare company Organon (NYSE:OGN) announced on Thursday that it has entered into a commercialisation agreement with Daiichi Sankyo Europe to distribute and promote Nilemdo in France, Denmark, Iceland, Sweden, Finland, and Norw...
8 January 2026 - Private equity firm Antin Infrastructure Partners (Euronext Paris:ANTIN) announced on Thursday that it has agreed to acquire Emsere from Dutch family investment platform Gryphion.Emsere, headquartered in Leiden in the Netherlands, is...
8 January 2026 - Arbele, a Hong Kong-based biotechnology company focused on developing innovative targeted cancer therapies, announced on Wednesday that it has received Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) for ...